COMITO, FRANCESCA
COMITO, FRANCESCA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Defining high-risk patients: beyond the 8the AJCC melanoma staging system
2025 Broseghini, E.; Veronesi, G.; Gardini, A.; Venturi, F.; Scotti, B.; Vespi, L.; Marchese, P. V.; Melotti, B.; Comito, F.; Corti, B.; Ferracin, M.; Dika, E.
Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis
2025 Raimondo, D.; Miscia, M.; Raffone, A.; Maletta, M.; Cipriani, L.; Marchese, P. V.; Comito, F.; Vicenti, R.; Cortese, F.; Pazzaglia, E.; Bertoldo, L.; Cobellis, L.; Seracchioli, R.
A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management
2024 Casadio, C.; Galvani, L.; De Giglio, A.; Tardio, M. L.; Melotti, B.; Sperandi, F.; Gelsomino, F.; Comito, F.; Casadei, C.
Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective study
2023 Scotti B.; Melotti B.; Baraldi C.; Comito F.; Venturi F.; Lambertini M.; Dika E.
Cemiplimab-Induced alopecia areata
2023 Piraccini, B. M.; Comito, F.; Melotti, B.; Stanganelli, I.; Medri, M.; Savoia, F.
Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence
2023 Lambertini M.; Comito F.; Melotti B.; Baracca M.F.; Dika E.
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
2023 Rossi, Simone; Cani, Ilaria; Raschi, Emanuel; Comito, Francesca; Rinaldi, Rita; Ardizzoni, Andrea; Guarino, Maria; Gelsomino, Francesco
Peripheral nervous system adverse events associated with immune checkpoint inhibitors
2023 Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lamberti G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M.
Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY
2023 Raschi E.; Comito F.; Massari F.; Gelsomino F.
Retreatment with sonidegib in a patient with multiple basal cell carcinomas and multiple comorbidities: a complex real-life scenario
2023 Comito, Francesca; Gagliano, Ambrogio; Sperandi, Francesca; Dika, Emi; Savoia, Francesco; Melotti, Barbara
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer
2022 Durante G.; Broseghini E.; Comito F.; Naddeo M.; Milani M.; Salamon I.; Campione E.; Dika E.; Ferracin M.
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: A single-institution experience
2022 Comito F.; Aprile M.; Pagani R.; Siepe G.; Sperandi F.; Gruppioni E.; Altimari A.; De Biase D.; Melotti B.
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis
2022 Viscardi G.; Tralongo A.C.; Massari F.; Lambertini M.; Mollica V.; Rizzo A.; Comito F.; Di Liello R.; Alfieri S.; Imbimbo M.; Della Corte C.M.; Morgillo F.; Simeon V.; Lo Russo G.; Proto C.; Prelaj A.; De Toma A.; Galli G.; Signorelli D.; Ciardiello F.; Remon J.; Chaput N.; Besse B.; de Braud F.; Garassino M.C.; Torri V.; Cinquini M.; Ferrara R.
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma
2022 Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melotti, Barbara
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab
2021 Comito F.; Nigro M.C.; Sperandi F.; Melotti B.; Ardizzoni A.
Non-coding RNA dysregulation in skin cancers
2021 Durante G.; Comito F.; Lambertini M.; Broseghini E.; Dika E.; Ferracin M.
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience
2020 Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F.
Circulating tumor cells in genitourinary tumors
2018 Massari, Francesco*; Di Nunno, Vincenzo; Comito, Francesca; Cubelli, Marta; Ciccarese, Chiara; Iacovelli, Roberto; Fiorentino, Michelangelo; Montironi, Rodolfo; Ardizzoni, Andrea
INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study
2018 Bersanelli M.; Giannarelli D.; Castrignano P.; Fornarini G.; Panni S.; Mazzoni F.; Tiseo M.; Rossetti S.; Gambale E.; Rossi E.; Papa A.; Cortellini A.; Lolli C.; Ratta R.; Michiara M.; Milella M.; Luca E.D.; Soraru M.; Mucciarini C.; Atzori F.; Banna G.L.; Torre L.L.; Vitale M.G.; Massari F.; Rebuzzi S.E.; Facchini G.; Schinzari G.; Tomao S.; Bui S.; Vaccaro V.; Procopio G.; Giorgi U.D.; Santoni M.; Ficorella C.; Sabbatini R.; Maestri A.; Natoli C.; Tursi M.D.; Maio M.D.; Rapacchi E.; Pireddu A.; Sava T.; Lipari H.; Comito F.; Verzoni E.; Leonardi F.; Buti S.
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis
2018 Grassi, Elisa; Durante, Sandra; Astolfi, Annalisa; Tarantino, Giuseppe; Indio, Valentina; Freier, Eva; Casadei, Riccardo; Ricci, Claudio; Comito, Francesca; Filippini, Daria; Formica, Francesca; Serra, Carla; Santini, Donatella; D'Errico, Antonietta; Minni, Francesco; Biasco, Guido; Di Marco, Mariacristina
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Defining high-risk patients: beyond the 8the AJCC melanoma staging system | Broseghini, E.; Veronesi, G.; Gardini, A.; Venturi, F.; Scotti, B.; Vespi, L.; Marchese, P. V.; M...elotti, B.; Comito, F.; Corti, B.; Ferracin, M.; Dika, E. | 2025-01-01 | ARCHIVES OF DERMATOLOGICAL RESEARCH | - | 1.01 Articolo in rivista | - |
| Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis | Raimondo, D.; Miscia, M.; Raffone, A.; Maletta, M.; Cipriani, L.; Marchese, P. V.; Comito, F.; Vi...centi, R.; Cortese, F.; Pazzaglia, E.; Bertoldo, L.; Cobellis, L.; Seracchioli, R. | 2025-01-01 | CURRENT ONCOLOGY | - | 1.01 Articolo in rivista | curroncol-32-00702.pdf |
| A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management | Casadio, C.; Galvani, L.; De Giglio, A.; Tardio, M. L.; Melotti, B.; Sperandi, F.; Gelsomino, F.;... Comito, F.; Casadei, C. | 2024-01-01 | ESMO GASTROINTESTINAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective study | Scotti B.; Melotti B.; Baraldi C.; Comito F.; Venturi F.; Lambertini M.; Dika E. | 2023-01-01 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | - | 1.01 Articolo in rivista | - |
| Cemiplimab-Induced alopecia areata | Piraccini, B. M.; Comito, F.; Melotti, B.; Stanganelli, I.; Medri, M.; Savoia, F. | 2023-01-01 | INTERNATIONAL JOURNAL OF TRICHOLOGY | - | 1.01 Articolo in rivista | cemiplimab_induced_alopecia_areata.7.pdf |
| Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence | Lambertini M.; Comito F.; Melotti B.; Baracca M.F.; Dika E. | 2023-01-01 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | - | 1.01 Articolo in rivista | tebentafusp.doc jeadv 2022.pdf |
| Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors | Rossi, Simone; Cani, Ilaria; Raschi, Emanuel; Comito, Francesca; Rinaldi, Rita; Ardizzoni, Andrea...; Guarino, Maria; Gelsomino, Francesco | 2023-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Peripheral nervous system adverse events associated with immune checkpoint inhibitors | Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lambert...i G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M. | 2023-01-01 | JOURNAL OF NEUROLOGY | - | 1.01 Articolo in rivista | Rossi_JN_2023.pdf |
| Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY | Raschi E.; Comito F.; Massari F.; Gelsomino F. | 2023-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Retreatment with sonidegib in a patient with multiple basal cell carcinomas and multiple comorbidities: a complex real-life scenario | Comito, Francesca; Gagliano, Ambrogio; Sperandi, Francesca; Dika, Emi; Savoia, Francesco; Melotti..., Barbara | 2023-01-01 | ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY | - | 1.01 Articolo in rivista | - |
| Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer | Durante G.; Broseghini E.; Comito F.; Naddeo M.; Milani M.; Salamon I.; Campione E.; Dika E.; Fer...racin M. | 2022-01-01 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | - | 1.01 Articolo in rivista | - |
| Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: A single-institution experience | Comito F.; Aprile M.; Pagani R.; Siepe G.; Sperandi F.; Gruppioni E.; Altimari A.; De Biase D.; M...elotti B. | 2022-01-01 | MELANOMA RESEARCH | - | 1.01 Articolo in rivista | - |
| Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis | Viscardi G.; Tralongo A.C.; Massari F.; Lambertini M.; Mollica V.; Rizzo A.; Comito F.; Di Liello... R.; Alfieri S.; Imbimbo M.; Della Corte C.M.; Morgillo F.; Simeon V.; Lo Russo G.; Proto C.; Prelaj A.; De Toma A.; Galli G.; Signorelli D.; Ciardiello F.; Remon J.; Chaput N.; Besse B.; de Braud F.; Garassino M.C.; Torri V.; Cinquini M.; Ferrara R. | 2022-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma | Comito, Francesca; Pagani, Rachele; Grilli, Giada; Sperandi, Francesca; Ardizzoni, Andrea; Melott...i, Barbara | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-00271-v2.pdf |
| Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab | Comito F.; Nigro M.C.; Sperandi F.; Melotti B.; Ardizzoni A. | 2021-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Non-coding RNA dysregulation in skin cancers | Durante G.; Comito F.; Lambertini M.; Broseghini E.; Dika E.; Ferracin M. | 2021-01-01 | ESSAYS IN BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
| Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience | Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F. | 2020-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | - |
| Circulating tumor cells in genitourinary tumors | Massari, Francesco*; Di Nunno, Vincenzo; Comito, Francesca; Cubelli, Marta; Ciccarese, Chiara; Ia...covelli, Roberto; Fiorentino, Michelangelo; Montironi, Rodolfo; Ardizzoni, Andrea | 2018-01-01 | THERAPEUTIC ADVANCES IN UROLOGY | - | 1.01 Articolo in rivista | - |
| INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study | Bersanelli M.; Giannarelli D.; Castrignano P.; Fornarini G.; Panni S.; Mazzoni F.; Tiseo M.; Ross...etti S.; Gambale E.; Rossi E.; Papa A.; Cortellini A.; Lolli C.; Ratta R.; Michiara M.; Milella M.; Luca E.D.; Soraru M.; Mucciarini C.; Atzori F.; Banna G.L.; Torre L.L.; Vitale M.G.; Massari F.; Rebuzzi S.E.; Facchini G.; Schinzari G.; Tomao S.; Bui S.; Vaccaro V.; Procopio G.; Giorgi U.D.; Santoni M.; Ficorella C.; Sabbatini R.; Maestri A.; Natoli C.; Tursi M.D.; Maio M.D.; Rapacchi E.; Pireddu A.; Sava T.; Lipari H.; Comito F.; Verzoni E.; Leonardi F.; Buti S. | 2018-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis | Grassi, Elisa; Durante, Sandra; Astolfi, Annalisa; Tarantino, Giuseppe; Indio, Valentina; Freier,... Eva; Casadei, Riccardo; Ricci, Claudio; Comito, Francesca; Filippini, Daria; Formica, Francesca; Serra, Carla; Santini, Donatella; D'Errico, Antonietta; Minni, Francesco; Biasco, Guido; Di Marco, Mariacristina | 2018-01-01 | PANCREATOLOGY | - | 1.06 Abstract in rivista | - |